FACTS ABOUT TARLOX-TKI REVEALED

Please begin to see the figure II for that modest molecule inhibitors of assorted kinases permitted by FDA matched for the phylogenetic map of the respective kinases. Chemical framework from the prototype tyrosine kinase inhibitor (TKI) imatinib, the epidermal advancement issue receptor (EGFR) TKI gefitinib, serine/threonine kinase inhibitor vemura